Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-054057
Filing Date
2021-08-31
Accepted
2021-08-31 16:03:39
Documents
2
Period of Report
2021-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2184
2 POA DOCUMENT poa.txt EX-24.3_1006457 3165
  Complete submission text file 0001209191-21-054057.txt   6684
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

EIN.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address
Callori Fred (Reporting) CIK: 0001843393 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39971 | Film No.: 211227031